(Q34215649)

31 July 2017

title

Sirolimus-induced pneumonitis complicated by pentamidine-induced phospholipidosis in a renal transplant recipient: a case report (English)

1 reference

31 July 2017

E J Filippone

1

1 reference

31 July 2017

J M Carson

2

1 reference

31 July 2017

R A Beckford

3

1 reference

31 July 2017

B C Jaffe

4

1 reference

31 July 2017

E Newman

5

1 reference

31 July 2017

B K Awsare

6

1 reference

31 July 2017

C Doria

7

1 reference

31 July 2017

J L Farber

8

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 September 2011

1 reference

Transplantation Proceedings

31 July 2017

published in

1 reference

31 July 2017

volume

43

1 reference

31 July 2017

issue

7

1 reference

31 July 2017

page(s)

2792-2797

1 reference

mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

mTOR inhibition: the learning curve in kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Sirolimus-induced pneumonitis: three cases and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Sirolimus-associated pulmonary toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Pneumonitis associated with sirolimus: clinical characteristics, risk factors and outcome--a single-centre experience and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Everolimus-associated pneumonitis in 3 heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Resolution of sirolimus-induced pneumonitis after conversion to everolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

The accumulation of pentamidine and the toxic effects of the drug, its selected analogues and metabolites on isolated alveolar cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Inhalation toxicity of aerosolized pentamidine isethionate in rats and dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

The pulmonary effects of long-term exposure to aerosol pentamidine: a 5-year surveillance study in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Pentamidine accumulates in rat liver lysosomes and inhibits phospholipid degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Assessment of drug-lipid complex formation by a high-throughput Langmuir-balance and correlation to phospholipidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Drug-induced phospholipidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.060

10.1016/J.TRANSPROCEED.2011.06.060

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference